JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$5.57B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.73B |
| 3 |
AbbVie
ABBV
|
+$1.02B |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$827M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$778M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.43B |
| 2 |
Amazon
AMZN
|
+$1.85B |
| 3 |
Cigna
CI
|
+$1.16B |
| 4 |
Microsoft
MSFT
|
+$1.08B |
| 5 |
Morgan Stanley
MS
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.47% |
| 2 | Financials | 11.13% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.29% |
| 5 | Industrials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRNS
3201
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $3.55M | ﹤0.01% |
311,925
+180,939
| +138% | +$2.49M |
|
|
ORC
3202
Orchid Island Capital
ORC
$1.33B
| $3.54M | ﹤0.01% |
144,699
+4,410
| +3% | +$111K |
|
3203
Universal Insurance Holdings
UVE
$1.2B
| $3.52M | ﹤0.01% |
270,092
+128,294
| +90% | +$1.75M |
|
|
SPK
3204
DELISTED
SPK Acquisition Corp. Common Stock
SPK
| $3.52M | ﹤0.01% |
+354,527
| New | +$3.51M |
|
3205
Mercer International
MERC
$31.6M
| $3.51M | ﹤0.01% |
302,854
+183,593
| +154% | +$2.13M |
|
3206
CALL
Phillips 66
PSX
$93.2B
| $3.51M | ﹤0.01% |
50,100
| – | – |
|
3207
Sanofi
SNY
$105B
| $3.51M | ﹤0.01% |
72,792
-58,678
| -45% | -$2.98M |
|
3208
CALL
Carnival Corporation Ltd
CCL
$38.5B
| $3.51M | ﹤0.01% |
140,200
+34,200
| +32% | +$796K |
|
3209
SPX Corp
SPXC
$10.9B
| $3.49M | ﹤0.01% |
65,272
-69,366
| -52% | -$4.25M |
|
|
GPX
3210
DELISTED
GP Strategies Corp.
GPX
| $3.46M | ﹤0.01% |
167,367
+18,155
| +12% | +$360K |
|
3211
PUT
CSX Corp
CSX
$92.9B
| $3.46M | ﹤0.01% |
116,400
| – | – |
|
3212
abrdn Physical Gold Shares ETF
SGOL
$7.47B
| $3.46M | ﹤0.01% |
205,330
+150,181
| +272% | +$2.58M |
|
3213
PUT
Bristol-Myers Squibb
BMY
$130B
| $3.44M | ﹤0.01% |
58,200
-46,200
| -44% | -$3.04M |
|
|
XLRN
3214
PUT
DELISTED
Acceleron Pharma
XLRN
| $3.44M | ﹤0.01% |
+20,000
| New | +$2.62M |
|
3215
ASE Group
ASX
$103B
| $3.44M | ﹤0.01% |
437,628
+325,229
| +289% | +$2.83M |
|
3216
Dime Commercial Bancshares
DCOM
$1.81B
| $3.43M | ﹤0.01% |
105,020
+31,777
| +43% | +$1.03M |
|
3217
iShares MSCI Australia ETF
EWA
$1.45B
| $3.43M | ﹤0.01% |
138,234
-1,741,154
| -93% | -$45M |
|
3218
Grove Collaborative
GROV
$44M
| $3.43M | ﹤0.01% |
+70,600
| New | +$3.44M |
|
3219
CALL
Norwegian Cruise Line
NCLH
$8.73B
| $3.42M | ﹤0.01% |
128,200
+78,200
| +156% | +$1.99M |
|
|
SQZ
3220
DELISTED
SQZ Biotechnologies Company
SQZ
| $3.42M | ﹤0.01% |
237,009
+54,980
| +30% | +$745K |
|
|
CMBM
3221
DELISTED
Cambium Networks
CMBM
| $3.42M | ﹤0.01% |
94,377
+25,223
| +36% | +$997K |
|
3222
Sportradar
SRAD
$4.09B
| $3.42M | ﹤0.01% |
+150,946
| New | +$3.85M |
|
|
CSW
3223
CSW Industrials
CSW
$5.62B
| $3.41M | ﹤0.01% |
26,727
-25,545
| -49% | -$3.18M |
|
3224
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$273M
| $3.41M | ﹤0.01% |
57,701
+6,815
| +13% | +$416K |
|
3225
Vanguard Long-Term Treasury ETF
VGLT
$10.3B
| $3.41M | ﹤0.01% |
38,860
-231,831
| -86% | -$20.9M |
|
Similar funds
JP Morgan Chase's Q3 2021 Portfolio in Review
As of Q3 2021, JP Morgan Chase held 7,104 positions worth $809B, down 3.5% from $838B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase withdrew a net $27.4B in Q3 2021, closing 499 positions and reducing 3,086 holdings. Its most notable exit was Weingarten Realty Investors, an estimated $401M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.
Against the trend, JP Morgan Chase opened a new position in Toast worth $138M.
- JP Morgan Chase's largest Q3 2021 buy was Toast: 2,760,295 shares worth $138M.
- JP Morgan Chase added most to Vanguard Short-Term Bond ETF in Q3 2021, an estimated $5.57B increase.
- JP Morgan Chase's biggest Q3 2021 reduction was Apple, cutting an estimated $2.43B.
- JP Morgan Chase fully exited Weingarten Realty Investors in Q3 2021, selling an estimated $401M.
- JP Morgan Chase's ten largest holdings make up 16% of its $809B portfolio in Q3 2021.
- JP Morgan Chase opened 647 new positions and closed 499 in Q3 2021.
- JP Morgan Chase's portfolio value fell 3.5% quarter-over-quarter to $809B.
Based on JP Morgan Chase's 13F filing for Q3 2021, filed 12 Nov 2021.